[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
January 1, 2005

Suture Tarsorrhaphy—Reply

Arch Ophthalmol. 2005;123(1):126. doi:10.1001/archopht.123.1.126-a

In reply

We appreciate the authors’ opinion and interest regarding our technique. Cyanoacrylate has been used for many years in ophthalmology and has been used by many experts in the field as an off-label use to create a temporary tarsorrhaphy. It is a well-known fact that cyanoacrylate has a limited duration of action when used in medical applications. However, for the patients who need decreased corneal exposure but who cannot tolerate an invasive tarsorrhaphy, such as those receiving anticoagulant therapy or those who won’t tolerate even a small needle to inject local anesthetic, as noted by the authors of the letter, this technique has its obvious advantages. The increased ease of application of the newer gel form of cyanoacrylate, for a patient bed-bound and in-house, makes this simple and noninvasive bedside procedure a very valuable one to have in our growing armamentarium of therapeutic interventions.

First Page Preview View Large
First page PDF preview
First page PDF preview